TRENDS IN PARASITOLOGY is a premier academic journal published by CELL PRESS, focusing on the dynamic field of parasitology and infectious diseases. With an ISSN of 1471-4922, this esteemed journal is recognized for its high impact within the research community, boasting a Q1 ranking in both the Infectious Diseases and Parasitology categories as of 2023. This places it among the top-tier journals in the field, as evidenced by its remarkable Scopus rankings, where it ranks #3 out of 79 in Parasitology and #29 out of 344 in Infectious Diseases. Spanning over two decades of scholarly contributions from 2001 to 2024, TRENDS IN PARASITOLOGY emphasizes the latest advancements, challenges, and innovative methodologies in parasitology, making it an invaluable resource for researchers, healthcare professionals, and students alike. With an increasing focus on open access initiatives, this journal not only promotes widespread dissemination of knowledge but also encourages collaboration across the global scientific community. Whether you are investigating novel interventions, exploring parasite evolution, or understanding host-pathogen interactions, TRENDS IN PARASITOLOGY remains at the forefront of research, driving forward the understanding of parasitic diseases.

International Journal for Parasitology, published by Elsevier Sci Ltd, stands as a premier platform for disseminating groundbreaking research in the fields of parasitology and infectious diseases. With an impressive impact factor represented by its Q1 quartile rankings in both Infectious Diseases and Parasitology for 2023, this journal commands significant attention within the scientific community. Operating since 1971, it has profoundly contributed to the understanding of parasitic infections and their implications for human health, occupying a distinguished position ranked #7 out of 79 in Parasitology and #64 out of 344 in Infectious Diseases according to Scopus metrics. Although the journal currently does not offer open access options, it ensures rigorous peer review and unparalleled academic integrity, providing researchers, professionals, and students with critical insights necessary for advancing knowledge and fostering innovations in parasitology. Together with its rich historical foundation and commitment to excellence, the journal is indispensable for anyone delving into the complexities of parasites and their impact on both host and ecosystem.

Parasites Hosts and Diseases is an emerging academic journal focusing on the intricate relationships between parasites, their hosts, and associated diseases. Published by the Korean Society of Parasitology in collaboration with Seoul National University College of Medicine, this journal is a significant contribution to the fields of Infectious Diseases and Parasitology, and it has secured a place in the Q3 category for both disciplines as of 2023. With an ISSN of 2982-5164 and an E-ISSN of 2982-6799, this open-access publication aims to foster scholarly communication and provide a platform for researchers to disseminate their findings on critical issues related to parasitic infections and the pathogenesis thereof. Although it is still in the early stages of its history, the journal has already positioned itself as a useful resource within its field, with Scopus rankings showing it as 48th of 79 in Parasitology and 210th of 344 in Infectious Diseases, indicating its growing influence and the potential for impactful research. Situated in South Korea, and via its open-access model, Parasites Hosts and Diseases is committed to reaching a global audience of scientists, healthcare professionals, and students, all dedicated to understanding and combating the challenges posed by parasitic diseases.

PARASITE IMMUNOLOGY, published by Wiley, is a leading journal in the field of immunology and parasitology, with an ISSN of 0141-9838 and E-ISSN of 1365-3024. Since its inception in 1979, it has played a pivotal role in advancing our understanding of host-parasite interactions, immunological responses to parasitic infections, and the mechanisms of immunological resistance. The journal is adeptly positioned within the academic community, currently holding a prestigious Q2 ranking in Parasitology and a Q3 ranking in Immunology for 2023, indicating its significant influence and relevance. Its comprehensive scope attracts a diverse readership, contributing to the discourse surrounding novel therapeutic approaches and emerging challenges in parasitic diseases. With a consistent convergence of research until 2024, PARASITE IMMUNOLOGY is an essential resource for researchers, professionals, and students seeking to deepen their knowledge and foster collaboration in these dynamic fields. Although it is not an open-access journal, the insights shared within its pages are invaluable for shaping future research trajectories.

ACTA PARASITOLOGICA, published by SPRINGER INT PUBL AG, stands as a pivotal journal within the field of Parasitology, boasting an ISSN of 1230-2821 and an E-ISSN of 1896-1851. Based in Germany, it has been providing valuable insights and research contributions since its inception, with publishing years converging from 1992 to 1994 and consistently from 1996 to 2024. The journal is recognized in the 2023 Category Quartiles as Q3 in Parasitology, indicating its significant impact and growing influence in the discipline, reflected in its Rank #43/79 in the Scopus Ranks for Immunology and Microbiology (Parasitology). Although not currently available in an Open Access format, ACTA PARASITOLOGICA remains a critical resource for researchers, professionals, and students alike, serving as a platform for the latest developments, methodologies, and discoveries in parasitic research. Its ongoing commitment to advancing the understanding of parasitic diseases and their impact on health and ecosystems underscores its importance in both academia and public health.

SYSTEMATIC PARASITOLOGY, a premier academic journal published by Springer, serves as a vital resource in the field of parasitology. Since its inception in 1979, this journal has committed itself to advancing the understanding of parasitic organisms and their interactions with hosts, thus playing a significant role in both basic and applied research. With an impactful contribution to the scientific community—evidenced by its Scopus ranking and its position in the third quartile (Q3) within the Parasitology category—the journal provides a platform for high-quality, peer-reviewed research that spans a variety of topics from molecular biology to ecology. Although not currently open access, SYSTEMATIC PARASITOLOGY remains essential for researchers, professionals, and students who seek to stay at the forefront of parasitological studies and contribute to ongoing developments in the domain. Published in the Netherlands, it continues to attract a diverse international readership, fostering a collaborative scientific environment.

ACTA TROPICA is a prestigious academic journal published by Elsevier, dedicated to advancing knowledge in the fields of Infectious Diseases, Insect Science, Parasitology, and Veterinary sciences. With an ISSN of 0001-706X and an E-ISSN of 1873-6254, it has established itself as a vital resource since its inception in 1945. The journal is recognized for its significant impact within the scientific community, boasting a Q2 ranking in Infectious Diseases and Parasitology, and a Q1 ranking in both Insect Science and Veterinary (miscellaneous) categories as of 2023. Specifically, it ranks #19 in Scopus for Parasitology and #129 for Infectious Diseases, underscoring its high visibility and relevance in these vital research arenas. ACTA TROPICA is a non-open access journal, ensuring high-quality peer-reviewed content that complements ongoing research and professional practices among scientists, researchers, and students. Explore groundbreaking studies and contribute to the ongoing dialogue within your field by selecting ACTA TROPICA as your next publication destination.

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.

MALARIA JOURNAL, published by BMC, is a leading open-access journal dedicated to the advancement of research in the field of malaria and related infectious diseases. Since its inception in 2002, this journal has established itself as a significant resource for the global scientific community, covering a wide range of topics, including epidemiology, pathology, treatment, and prevention strategies for malaria. With an impressive Q1 ranking in both Infectious Diseases and Parasitology categories as of 2023, the journal is committed to fostering high-quality research that contributes to the understanding and control of malaria. As an open-access platform, it ensures that vital findings and insights are freely accessible to researchers, practitioners, and students worldwide, facilitating collaboration and informing public health strategies. The journal's relevance is underscored by its competitive Scopus rankings, which further highlight its impact in the realms of Immunology, Microbiology, and Medicine. Join the community of scholars and practitioners dedicated to combating one of the world's most pressing health challenges.